ROSEMARIE SCHMANDT to Uterine Neoplasms
This is a "connection" page, showing publications ROSEMARIE SCHMANDT has written about Uterine Neoplasms.
Connection Strength
0.042
-
A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed m?llerian tumors with evaluation of potential molecular targets. Gynecol Oncol. 2003 Sep; 90(3):529-36.
Score: 0.042